Actualizat acum 1 minut

Investment Plan for Europe: EIB grants financing to Biofrontera

19 Mai 2017
Exprimă-ţi opinia liber. Creează sau semnează o petiţie online.

The EIB will grant financing of up to EUR 20 million to the German biopharmaceutical company Biofrontera AG. The loan agreement has been signed today in Luxemburg. EUR 10m will be available for disbursement from signature, and further installments will be disbursed based on pre-defined commercial and regulatory milestones. EIB’s transaction with Biofrontera was made possible by the support of the “European Fund for Strategic Investments” (EFSI). EFSI is the central pillar of the “Investment Plan for Europe”, in which EIB Group and the European Commission are strategic partners.... continuare


Subiecte asemanatoare

Monitorizarea presei
  • Informează-te eficient!

    Urmăreşte articolele selectate automat, pe baza cuvintelor definite de tine!

    Primeşte ştirile pe mail, imediat ce sunt publicate!